actelion almorexant GSK Pages on BioPortfolio:

BioPortfolio - actelion almorexant GSK
actelion almorexant GSK - BioPortfolio. ... US patent | almorexant US patent | actelion almorexant GSK | Primovist | actelion.com | actelion drug discovery ...
http://www.bioportfolio.com/search/actelion_almorexant_GSK_....

BioPortfolio - ACTELION PHARMACEUTICALS LTD vat
23 Sep 2008 ... BioPortfolio - ACTELION PHARMACEUTICALS LTD vat BioPortfolio - actelion almorexant GSK BioPortfolio Biotechnology Pharmaceutical Healthcare ...
http://www.bioportfolio.com/search/ACTELION_PHARMACEUTICALS_...

BioPortfolio - ALMOREXANT CHEMICAL SYNTHESIS
BioPortfolio - ALMOREXANT CHEMICAL SYNTHESIS US patent | almorexant US ... BioPortfolio - actelion almorexant GSK BioPortfolio - actelion pharmaceuticals .
...
http://www.bioportfolio.com/search/ALMOREXANT_CHEMICAL_SYNTH...

BioPortfolio - actelion
LTD vat | actelion pharmaceuticals canada | actelion pharmaceuticals ltd ... BioPortfolio - actelion almorexant GSK BioPortfolio - actelion . ...
http://www.bioportfolio.com/search/actelion.html...

BioPortfolio - Actelion Pharmaceuticals Ltd
BioPortfolio - actelion almorexant GSK BioPortfolio - actelion pharmaceuticals ltd. vat number GlaxoSmithKline and Actelion Ltd announced today that they . ...
http://www.bioportfolio.com/search/Actelion_Pharmaceuticals_...

BioPortfolio - PRIMARY INSOMNIA FIRST DISCOVERED
BioPortfolio - PRIMARY INSOMNIA FIRST DISCOVERED BioPortfolio - actelion almorexant GSK Actelion will continue to lead the ongoing Phase III program with
...
http://www.bioportfolio.com/search/PRIMARY_INSOMNIA_FIRST_DI...

Forecast Insight: Insomnia Orexin and serotonin receptor ...
Almorexant from Actelion and GlaxoSmithKline is expected to achieve the greatest sales of all late-stage pipeline products 33 Marketed non-barbiturate plain ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_501.html...

Forecast Insight: Insomnia Orexin and serotonin receptor ...
Actelion's orexin receptor antagonistalmorexantis forecast to be the main ... deal with GlaxoSmithKline, which will enable the realization of almorexant's ...
http://www.bioportfolio.com/cgi-bin/acatalog/Forecast_Insigh...

BioPortfolio - managing director glaxosmithkline
actelion almorexant GSK - BioPortfolio. ... Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680
...
http://www.bioportfolio.com/search/managing_director_glaxosm...

Results from other life science and pharmaceutical sites:

GlaxoSmithKline and Actelion enter into exclusive collaboration to ...
14 Jul 2008 ... Under the terms of the agreement, GSK will receive exclusive worldwide rights to co-develop and co-commercialise almorexant. Actelion will ...
http://www.gsk.com/media/pressreleases/2008/2008_pressreleas...

Actelion - Almorexant in Clinical Development
21 Oct 2008 ... As of October 2008 the Actelion/GSK collaboration on almorexant was fully operational and the two companies expect to initiate in the coming ...
http://www.actelion.com/uninet/www/www_main_p.nsf/Content/Al...

Actelion - Company Partnerships
22 Jul 2008 ... Actelion will continue to lead the ongoing Phase III program with almorexant in primary insomnia, with GSK contributing 40 percent of the ...
http://www.actelion.com/uninet/www/www_main_p.nsf/Content/Co...

Actelion - Media Release Archive Content
14 Jul 2008 · Actelion and GlaxoSmithKline enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders and beyond ...
http://www.actelion.com/uninet/www/www_main_p.nsf/Content/Me...

News in brief : Article : Nature Reviews Drug Discovery
GlaxoSmithKline (GSK) and Actelion have entered into an exclusive worldwide collaboration (excluding Japan) for almorexant to treat primary insomnia. ...
http://www.nature.com/nrd/journal/v7/n8/full/nrd2650.html...

Actelion - The Company
Pulmonary Arterial Hypertension. Actelion and GlaxoSmithKline enter into. almorexant collaboration. Actelion and Nippon Shinyaku enter into a li- ...
http://www.actelion.com/uninet/www/www_main_p.nsf/Content/Co...

Deal Highlights
GSK agrees to codevelop Actelion's. almorexant. GlaxoSmithKline plc (GSK) has obtained exclusive worldwide. (excluding Japanese) development and ...
http://www.biomedcentral.com/content/pdf/cd-939534.pdf...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.